Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340841 · ClinicalTrials.gov registry record · Phase 1
LEMURS SSI: Evaluation of Behavioral Incentives
A Phase 1 study of Incentives, sponsored by University of Vermont.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06340841: Recruiting Phase 1 study of Incentives, sponsored by University of Vermont.
NCT06340841 is a Phase 1 study of Incentives that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 200 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06340841, a Phase 1 study of Incentives, is actively recruiting participants, sponsored by University of Vermont.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this substudy is to determine if a brief single-session-intervention (SSI) coupled with different incentive strategies to support engaging in wellness-related activities.
Primary Outcome
Number of wellness activities completed
Conditions Studied
Interventions
- BEHAVIORAL Personal Incentives
- BEHAVIORAL Personal Restorative Incentives
- BEHAVIORAL Charity Incentives
- BEHAVIORAL Charity Restorative Incentives
Study Locations (1)
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2028-05-31 |
| Phase | Phase 1 |
What NCT06340841 shows while recruiting
NCT06340841 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher).
The record links to 1 condition, with Incentives appearing as the primary indexed condition, and to 4 interventions - of which Personal Incentives is the first listed.
NCT06340841 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT06340841 about?
NCT06340841 is a clinical study titled "LEMURS SSI: Evaluation of Behavioral Incentives". The goal of this substudy is to determine if a brief single-session-intervention (SSI) coupled with different incentive strategies to support engaging in wellness-related activities.
What is the current status of trial NCT06340841?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2024-02-12. Estimated completion is 2028-05-31.
What conditions does trial NCT06340841 study?
This clinical trial studies the following conditions: Incentives.
What interventions are being tested in trial NCT06340841?
The interventions under investigation include: Personal Incentives (BEHAVIORAL), Personal Restorative Incentives (BEHAVIORAL), Charity Incentives (BEHAVIORAL), Charity Restorative Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT06340841?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340841 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06340841's enrollment target sits among peer trials
200 259th of 2000 higher than 1,724 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI